In-vitro Diagnostics Enzymes Top Companies - Recent Developments, Business Strategy, Deal Strategy, Patent Strategy, Benchmarking and Management Outlook

In-vitro Diagnostics Enzymes Market Size Analysis and Top Companies

The global in-vitro diagnostics enzymes market size is anticipated to reach around USD 4.10 billion by 2033 from USD 2.20 billion in 2023, growing at a CAGR of 6.42% from 2024 to 2033. The top companies operating in the in-vitro diagnostics enzymes market are Biocatalysts Ltd., Amicogen, Dyadic International, BBI Solutions, Affymetrix, American Laboratories, Merck KGaA, Codexis, Inc., F. Hoffmann-La Roche Ltd., Amano Enzyme Inc., Advanced Enzymes Technologies Ltd., and Others.

Market 

In-vitro Diagnostics Enzymes Key Players

• Biocatalysts Ltd.
• Amicogen
• Dyadic International
• BBI Solutions
• Affymetrix
• American Laboratories
• Merck KGaA
• Codexis, Inc.
• F. Hoffmann-La Roche Ltd.
• Amano Enzyme Inc.
• Advanced Enzymes Technologies Ltd.

Recent Developments

• In June 2023, GenWorks Health, a Bengaluru-based startup, launched an IVD test for malaria and dengue. This test includes rapid card test kits.
• In September 2023, NeoDX Biotech lab launched an IVD kit for detecting autoimmune disorders. It’s a real-time PCR- a technology-based kit to improve healthcare service and enhance testing abilities.

We have prepared a service to support you. please feel free to contact us at sales@precedenceresearch.com | +1 804 441 9344